Approval · Notice of Compliance 259 · 2003
DOSTINEX: Notice of Compliance 259
Issued September 19, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 259
- Date
- September 19, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Dopamine receptor agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOSTINEX | 02242471 | Marketed |
Medicinal ingredients
- CABERGOLINE 0.5 MG per TAB